Investor insights
Sectors invested in
Funding rounds participated in
$32M sweet spot round size
Most of their 12 investments are in rounds between $15M and $55M
Investor type
Basic info
Industry
Sectors
Date founded
2017
Investments made
Evogene raised $8.5M on July 17, 2023
Investors: Altium Capital
Aligned raised $34M on February 24, 2022
Investors: Alliance Advisors, LLC, GSR, ConsenSys and Altium Capital
Undisclosed raised $30M on September 3, 2021
Investors: Innogest Capital, Ikarian Capital LLC, Longview Ventures, RTW Investments, LP, Sio Capital Management LLC, Surveyor Capital, Acorn Bioventures, Affinity Asset Advisors and Altium Capital
Ocuphire Pharma raised $15M on June 8, 2021
Investors: Lincoln Park Capital, LLC, Ayrton Capital and Altium Capital
X4 Pharmaceuticals raised $55M on March 19, 2021
Investors: Lincoln Park Capital, LLC, Ikarian Capital LLC, Abingworth, OrbiMed Advisors, Driehaus Capital Management LLC, Monashee Investment Management LLC, Sio Capital Management LLC and Altium Capital
3-V Biosciences raised $80M on February 11, 2021
Investors: Partner Fund Management, 惠每资本, Kleiner Perkins, Ascletis Pharma Inc., The Invus Group and Altium Capital
Undisclosed raised $90M on February 10, 2021
Investors: Affinity Asset Advisors, COLLE CAPITAL, GV, Zepp Health, Nextrans Vietnam and Altium Capital
Undisclosed raised $90M on February 10, 2021
Investors: Nextrans Vietnam, COLLE CAPITAL, GV, Tamar Capital, MINT Venture Partners, Zepp Health and Altium Capital
Leading BioSciences, Inc. raised $23M on December 17, 2020
Investors: Altium Capital
Undisclosed raised $34M on December 15, 2020
Investors: Ikarian Capital LLC, The Invus Group and Altium Capital